Xin Guan Selected Research

Dosage Forms (Dosage Form)

11/2016	Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
1/2016	A Promising Emodin-Loaded Poly (Lactic-Co-Glycolic Acid)-d-α-Tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles for Liver Cancer Therapy.
1/2016	Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
1/2015	A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Guan Research Topics

Disease

58	Neoplasms (Cancer) 06/2022 - 12/2004
13	Infections 01/2022 - 04/2011
12	Breast Neoplasms (Breast Cancer) 08/2022 - 12/2003
11	Inflammation (Inflammations) 11/2022 - 12/2007
11	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2003
9	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2012
6	Lung Neoplasms (Lung Cancer) 09/2022 - 01/2015
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 06/2018
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2004
6	Liver Neoplasms (Liver Cancer) 10/2020 - 01/2015
5	Carcinoma (Carcinomatosis) 01/2022 - 01/2015
5	Hypoxia (Hypoxemia) 01/2022 - 01/2017
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 02/2019
4	Carcinogenesis 01/2022 - 09/2018
4	Kidney Neoplasms (Kidney Cancer) 01/2019 - 01/2018
3	Brain Injuries (Brain Injury) 11/2022 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2018
3	Parkinson Disease (Parkinson's Disease) 11/2021 - 01/2017
3	Wounds and Injuries (Trauma) 10/2021 - 01/2018
3	Microsatellite Instability 04/2021 - 01/2015
3	Infarction (Infarctions) 01/2021 - 01/2018
3	Genomic Instability 01/2021 - 01/2007
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 06/2015
3	Melanoma (Melanoma, Malignant) 01/2018 - 11/2003
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2019
2	Alcoholism (Alcohol Abuse) 01/2022 - 01/2022
2	Lymphatic Metastasis 10/2021 - 01/2020
2	Reperfusion Injury 05/2021 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 04/2021 - 12/2003
2	Rectal Neoplasms (Rectal Cancer) 04/2021 - 01/2015
2	Diabetes Mellitus 03/2021 - 07/2012
2	Vomiting 02/2021 - 01/2020
2	Nausea 02/2021 - 01/2020
2	Myocardial Infarction 01/2021 - 08/2020
2	Ischemia 01/2021 - 01/2019
2	Fibrosis (Cirrhosis) 01/2021 - 10/2020
2	Ischemic Stroke 01/2021 - 11/2020
2	Starvation 11/2020 - 11/2019
2	Neuroinflammatory Diseases 11/2020 - 01/2019
2	Hemorrhage 01/2020 - 12/2007

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
18	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2014
10	Pharmaceutical PreparationsIBA 10/2022 - 01/2015
8	Biological ProductsIBA 08/2022 - 12/2003
7	Formaldehyde (Formol)FDA Link 06/2019 - 01/2018
7	ParaffinIBA 06/2019 - 01/2018
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
6	Therapeutic UsesIBA 01/2021 - 02/2012
5	RNA (Ribonucleic Acid)IBA 06/2022 - 09/2019
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2013
5	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 03/2010
5	AntigensIBA 09/2020 - 02/2010
5	Succinic Acid (Succinate)IBA 11/2016 - 01/2015
5	polyethylene glycol 1000IBA 11/2016 - 01/2015
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2004
4	Neuroprotective AgentsIBA 01/2021 - 01/2017
4	Peptides (Polypeptides)IBA 11/2020 - 02/2010
4	tocophersolanIBA 11/2016 - 01/2015
4	Dosage Forms (Dosage Form)IBA 11/2016 - 01/2015
3	Interleukin-8 (Interleukin 8)IBA 01/2022 - 12/2019
3	CytokinesIBA 01/2022 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 12/2004
3	AntibodiesIBA 01/2021 - 01/2019
3	Indicators and Reagents (Reagents)IBA 01/2021 - 07/2012
3	Small Interfering RNA (siRNA)IBA 01/2020 - 08/2013
3	Trinitrotoluene (TNT)IBA 01/2018 - 12/2007
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2016 - 01/2016
3	cyclonite (RDX)IBA 01/2014 - 07/2009
2	LipopolysaccharidesIBA 11/2022 - 01/2019
2	ZincIBA 09/2022 - 08/2022
2	disulfiram-copperIBA 01/2022 - 01/2022
2	Serine Proteases (Serine Protease)IBA 01/2022 - 08/2015
2	Disulfiram (Antabuse)FDA Link 01/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2013
2	LuciferasesIBA 01/2022 - 02/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 01/2019
2	CateninsIBA 01/2022 - 03/2013
2	EnzymesIBA 01/2022 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 12/2021 - 01/2021
2	C-Reactive ProteinIBA 12/2021 - 01/2018
2	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2019
2	Enhancer of Zeste Homolog 2 ProteinIBA 10/2021 - 03/2021
2	InterleukinsIBA 10/2021 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 12/2004
2	CarcinogensIBA 01/2021 - 12/2020
2	secukinumabIBA 11/2020 - 11/2020
2	Nucleic AcidsIBA 09/2020 - 05/2018
2	GTP-Binding Proteins (G-Protein)IBA 04/2020 - 12/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2015

Therapy/Procedure

27	Therapeutics 01/2022 - 04/2011
13	Drug Therapy (Chemotherapy) 02/2022 - 01/2015
6	Immunotherapy 01/2022 - 12/2004
5	Length of Stay 01/2020 - 07/2012
2	Radiotherapy 01/2022 - 01/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021 - 01/2019
2	Operative Surgical Procedures 10/2021 - 09/2014